Sign In
Buy AMLX
$13.20
-0.0900 (-0.677%)
At Close: Jun 03, 2026
The Year's First Three IPOs All Went 'Clunk.' This Is Why.
03:26pm, Friday, 07'th Jan 2022
Amylyx Pharmaceuticals raised $190 million, CinCor Pharma collected nearly $194 million, and Vigil Neuroscience came in at $98 million.
Three Biotech IPOs Started Trading. Here's How the Stocks Did.
01:36pm, Friday, 07'th Jan 2022
Amylyx Pharmaceuticals raised $190 million, CinCor Pharma collected nearly $194 million, and Vigil Neuroscience came in at $98 million.
2022 IPO Market Kicks Off With 3 Biotechs Set To Trade On Friday
09:21am, Tuesday, 04'th Jan 2022
Three biotechs launched their offerings on Monday, set to be the first IPOs of the new year. Amylyx is developing oral small molecule therapies for amyotrophic lateral sclerosis and a broad range of n
Amylyx Pharmaceuticals: Targeting Multiple Destructive Pathways To Reduce Neuronal Death
02:42pm, Monday, 03'rd Jan 2022
Amylyx Pharmaceuticals is developing combo therapies to reduce neuronal death in ALS and other neurodegenerative diseases by targeting multiple destructive pathways.
